We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Surgical Innovations Group Plc | LSE:SUN | London | Ordinary Share | GB0004016704 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 0.50 | 0.40 | 0.60 | 0.50 | 0.50 | 0.50 | 3,335 | 08:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Surgical,med Instr,apparatus | 11.34M | 264k | 0.0003 | 16.67 | 4.66M |
TIDMSUN
RNS Number : 5114R
Surgical Innovations Group PLC
28 February 2019
28 February 2019
Surgical Innovations Group plc
("Surgical Innovations" or "the Company")
Exercise of Options & Total Voting Rights
Surgical Innovations (AIM: SUN), the designer and manufacturer of innovative technology for minimally invasive surgery, announces that it has today issued and allotted a total of 5,000,000 ordinary shares of 1 penny each in the capital of the Company following an exercise of options by certain employees of the Company. Application will be made to the London Stock Exchange for admission of the 5,000,000 ordinary Shares to trading on AIM ("Admission") and it is expected that Admission will take place and that trading will commence on AIM on 6 March 2019.
Total Voting Rights
Following Admission, the Company will have 787,566,177 ordinary Shares in issue with each share carrying the right to one vote. The Company has no ordinary Shares held in treasury. The total number of voting rights in the Company following Admission will therefore be 787,566,177.
For further information contact:
Surgical Innovations Group Plc www.sigroupplc.com Nigel Rogers, Executive Chairman Tel: +44 (0)113 230 7597 Melanie Ross, COO and CFO Walbrook PR (Financial PR & Investor Tel: +44 (0)20 7933 8780 or si@walbrookpr.com Relations) Paul McManus Mob: +44 (0)7980 541 893 Lianne Cawthorne Mob: +44 (0)7584 391 303 N+1 Singer (Nominated Adviser and Broker) +44 (0)20 7496 3000 Richard Lindley Rachel Hayes
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
END
MSCUWAWRKNAUUAR
(END) Dow Jones Newswires
February 28, 2019 13:18 ET (18:18 GMT)
1 Year Surgical Innovations Chart |
1 Month Surgical Innovations Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions